Oral Cavity Neoplasm: Clinical Trials

3 trials for Oral Cavity Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 terminated. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Terminated 1
Not applicable1Recruiting 1

Follow Oral Cavity Neoplasm: new trials by email Literature Review of Oral Cavity Neoplasm trials Research Report on Oral Cavity Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
Camrelizumab, Paclitaxel, carboplatin - Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms
Phase 2Not yet recruitingNational Medical Research Radiological Centre of the Ministry of Health of Russia502026-02-012026-02-10
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study - Oral Cavity Neoplasm, Oropharyngeal Neoplasm
Phase 2TerminatedNational Cancer Institute (NCI)62018-05-312023-03-08
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
High-Resolution Microendoscopy, Multispectral Imaging, Proflavine - Oral Cavity Neoplasm
Not applicableRecruitingM.D. Anderson Cancer Center2752010-12-302026-07-29

Narrower conditions

Mouth Neoplasms (3)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Laryngeal Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)

Broader conditions

Head and Neck Neoplasms (3)  ·  Mouth Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Stomatognathic Diseases (3)  ·  Carcinoma (2)  ·  Carcinoma, Squamous Cell (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Otorhinolaryngologic Neoplasms (2)  ·  Laryngeal Diseases (1)  ·  Pharyngeal Diseases (1)  ·  Pharyngeal Neoplasms (1)  ·  Respiratory Tract Diseases (1)

Interventions

Carboplatin (1)  ·  Paclitaxel (1)  ·  Proflavine (1)  ·  camrelizumab (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  National Medical Research Radiological Centre of the Ministry of Health of Russia (1)

Countries

United States (2)  ·  Russia (1)

Top investigators

Ann Gillenwater (1)  ·  Frank G Ondrey (1)  ·  Larisa V. Bolotina, MD, PhD (1)

NIH funding

N01CN00033 (1), P30CA014520 (1)